Current Status of Laboratory Diagnosis for COVID-19: A Narrative Review.

COVID-19 PCR SARS-CoV-2 laboratory diagnosis serological test

Journal

Infection and drug resistance
ISSN: 1178-6973
Titre abrégé: Infect Drug Resist
Pays: New Zealand
ID NLM: 101550216

Informations de publication

Date de publication:
2020
Historique:
received: 22 05 2020
accepted: 05 07 2020
entrez: 18 8 2020
pubmed: 18 8 2020
medline: 18 8 2020
Statut: epublish

Résumé

The outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the related disease (COVID-19) has spread rapidly to pandemic proportions, increasing the demands on healthcare systems for the containment and management of COVID-19. One of the critical issues to be addressed is the improvement in laboratory diagnosis and screening of large portions of the population to stop the virus spreading. Currently, the laboratory diagnosis of SARS-CoV-2 infection and the related disease is based on the research of viral RNA with rt-PCR methods in upper and lower respiratory airways. Serological tests to detect SARS-CoV-2 antibodies could help physicians and healthcare workers to support COVID-19 diagnosis and follow-up and perform population screening. Our review, using MEDLINE and EMBASE, summarizes the current knowledge of direct and serological tests performed to research RNA, antigens, or antibodies for SARS-CoV-2, evaluating the advantages and drawbacks for specific tests.

Identifiants

pubmed: 32801804
doi: 10.2147/IDR.S264020
pii: 264020
pmc: PMC7413717
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

2657-2665

Informations de copyright

© 2020 Russo et al.

Déclaration de conflit d'intérêts

The authors report no funding and no conflicts of interest for this work.

Références

Lancet. 2020 Feb 22;395(10224):565-574
pubmed: 32007145
Front Cell Dev Biol. 2020 May 22;8:410
pubmed: 32574318
Nature. 2016 Mar 3;531(7592):118-21
pubmed: 26935699
N Engl J Med. 2004 Apr 22;350(17):1731-9
pubmed: 15102999
Clin Infect Dis. 2020 Apr 09;:
pubmed: 32271374
Lancet Infect Dis. 2020 May;20(5):565-574
pubmed: 32213337
J Infect. 2020 May 29;:
pubmed: 32474034
J Med Virol. 2020 Mar 30;:
pubmed: 32227490
Lancet. 2020 Feb 15;395(10223):514-523
pubmed: 31986261
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Clin Chem Lab Med. 2020 Jun 25;58(7):1070-1076
pubmed: 32172228
Science. 2020 Mar 13;367(6483):1260-1263
pubmed: 32075877
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
J Med Virol. 2006 Jan;78(1):1-8
pubmed: 16299724
Clin Chem. 2020 Jul 1;66(7):977-979
pubmed: 32282874
Cell. 2020 Apr 16;181(2):281-292.e6
pubmed: 32155444
Annu Rev Virol. 2016 Sep 29;3(1):237-261
pubmed: 27578435
JCI Insight. 2019 Feb 21;4(4):
pubmed: 30830861
Nat Med. 2020 Jun;26(6):845-848
pubmed: 32350462
Microb Biotechnol. 2020 Jul;13(4):950-961
pubmed: 32333644
J Med Virol. 2020 Jul;92(7):903-908
pubmed: 32219885
Emerg Microbes Infect. 2020 Dec;9(1):998-1007
pubmed: 32306853
Diagnostics (Basel). 2020 Apr 05;10(4):
pubmed: 32260471
J Virol. 1998 Aug;72(8):6838-50
pubmed: 9658133
J Med Virol. 2020 Apr 9;:
pubmed: 32270882
Respir Med. 2020 Apr - May;165:105935
pubmed: 32308203
Diabetes Care. 2020 Jul;43(7):1408-1415
pubmed: 32430456
JAMA. 2020 Feb 7;:
pubmed: 32031570
Clin Infect Dis. 2020 Mar 28;:
pubmed: 32221519
Clin Chem Lab Med. 2020 Jun 25;58(7):1081-1088
pubmed: 32301749
Science. 2020 May 15;368(6492):779-782
pubmed: 32277040
J Med Virol. 2020 Jun;92(6):639-644
pubmed: 32141619
Virusdisease. 2020 Mar;31(1):13-21
pubmed: 32206694
Braz J Infect Dis. 2020 Mar - Apr;24(2):180-187
pubmed: 32330437
Nat Rev Microbiol. 2016 Aug;14(8):523-34
pubmed: 27344959
JMIR Public Health Surveill. 2020 Apr 16;6(2):e18980
pubmed: 32297868
Nat Rev Microbiol. 2019 Mar;17(3):181-192
pubmed: 30531947
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
J Infect Dis. 2005 Jun 15;191(12):2033-7
pubmed: 15897988
Ann Intern Med. 2020 Jun 2;172(11):726-734
pubmed: 32282894
Cell Host Microbe. 2020 Mar 11;27(3):325-328
pubmed: 32035028
J Infect. 2020 Jul;81(1):e45-e50
pubmed: 32298676
Science. 2020 Mar 27;367(6485):1444-1448
pubmed: 32132184
J Clin Microbiol. 2020 May 26;58(6):
pubmed: 32295895
Lancet. 2020 Apr 4;395(10230):1101-1102
pubmed: 32247384
Sci China Life Sci. 2020 Mar;63(3):457-460
pubmed: 32009228
Infect Genet Evol. 2020 Apr;79:104212
pubmed: 32004758
Gene Rep. 2020 Apr 16;:100682
pubmed: 32300673
Nat Commun. 2017 Apr 10;8:15092
pubmed: 28393837
Nat Commun. 2020 Mar 27;11(1):1620
pubmed: 32221306
Int J Antimicrob Agents. 2020 May;55(5):105950
pubmed: 32234465
Radiology. 2020 Sep;296(3):E145-E155
pubmed: 32301646
J Med Virol. 2020 Feb 27;:
pubmed: 32104917
Cell Mol Immunol. 2020 May;17(5):555-557
pubmed: 32235915
Nature. 2020 May;581(7807):215-220
pubmed: 32225176
J Microbiol Immunol Infect. 2020 Mar 31;:
pubmed: 32265180
Clin Chem. 2020 Apr 1;66(4):549-555
pubmed: 32031583
Emerg Microbes Infect. 2020 Dec;9(1):747-756
pubmed: 32196430
Cell. 2020 May 14;181(4):894-904.e9
pubmed: 32275855
Diagnostics (Basel). 2020 Mar 18;10(3):
pubmed: 32197339
Diabetes Metab. 2020 May 21;:
pubmed: 32447102

Auteurs

Antonio Russo (A)

Department of Mental Health and Public Medicine, Infectious Diseases Unit, University of Campania Luigi Vanvitelli, Naples, Italy.

Carmine Minichini (C)

Department of Mental Health and Public Medicine, Infectious Diseases Unit, University of Campania Luigi Vanvitelli, Naples, Italy.

Mario Starace (M)

Department of Mental Health and Public Medicine, Infectious Diseases Unit, University of Campania Luigi Vanvitelli, Naples, Italy.

Roberta Astorri (R)

Department of Mental Health and Public Medicine, Infectious Diseases Unit, University of Campania Luigi Vanvitelli, Naples, Italy.

Federica Calò (F)

Department of Mental Health and Public Medicine, Infectious Diseases Unit, University of Campania Luigi Vanvitelli, Naples, Italy.

Nicola Coppola (N)

Department of Mental Health and Public Medicine, Infectious Diseases Unit, University of Campania Luigi Vanvitelli, Naples, Italy.

Classifications MeSH